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Impact of visible light on skin health:
The role of antioxidants and free radical
quenchers in skin protection
Henry W. Lim, MD,a Indermeet Kohli, PhD,a Eduardo Ruvolo, MS,b Ludger Kolbe, PhD,b and
Iltefat H. Hamzavi, MDa
Detroit, Michigan and Morristown, New Jersey
Until recently, the primary focus of photobiology has centered on the impact of UV radiation on skin
health, including DNA damage and oncogenesis; however, the significant effects of visible light (VL) on
skin remain grossly underreported. VL has been reported to cause erythema in individuals with light skin
(Fitzpatrick skin types [FSTs] I-III) and pigmentary changes in individuals with dark skin types (FSTs IV-VI).
These effects have importance in dermatologic diseases and potentially play a role in conditions aggravated
by sun exposure, including phototoxicity in patients with FSTs I to III and post-inflammatory hyperpigmentation and melasma in patients with FSTs IV to VI. The induction of free radicals, leading to the
generation of reactive species, is one driving mechanism of VL-induced skin pathologies, leading to the
induction of melanogenesis and hyperpigmentation. Initial clinical studies have demonstrated the
effectiveness of topical sunscreen with antioxidant combinations in inhibiting VL 1 UV-A1-induced
erythema in FSTs I to III and reducing pigmentation in FSTs IV to VI. Antioxidants may help prevent the
worsening of pigmentary disorders and can be incorporated into photoprotective strategies. It is
essential that dermatologists and the public are aware of the impact of VL on skin, especially in patients
with skin of color, and understand the available options for VL protection. ( J Am Acad Dermatol
2022;86:S27-37.)
Key words: antioxidants; free radicals; photoprotection; visible light.

VISIBLE LIGHT SPECTRUM AND VISIBLE
LIGHT SOURCES
Electromagnetic radiation from the sun is the
major source of visible light (VL) exposure on our
skin. VL encompasses the electromagnetic radiation
visible to the human eye, spanning from 400 to
700 nm of the electromagnetic radiation, and can be
divided by color and wavelength (Fig 1)1-3; however,
it is imperative to understand that the VL wavelength
cutoffs are arbitrary and the VL spectrum is a
continuum from the tail end of the longwavelength UV-A spectra.4 Recent data demonstrate
the synergistic effects between VL and UV-A1 on
erythema and pigmentation compared to those
induced by pure VL; however, although both UVA1 and VL can induce pigmentation in dark skin
types, VL-induced pigmentation is darker and more
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sustained than UV-Aeinduced pigmentation.4,5 One
major issue in the underreporting of VL-induced
pathologies is the use of VL sources with different
spectral outputs for VL phototesting due to a lack of
testing guidelines currently available.4
Other sources of VL include light-emitting diodes,
flash lamps, computers, televisions, and cell phones.6,7
Of importance to skin health, violet-blue light, often
referred to as high-energy VL, spans from 400 to
500 nm on the VL spectrum and appears to have the
most significant biological effects on the skin when
compared to red light, which spans from 620 to
700 nm.6-8 It is important to note that the relative
intensity of blue light (420-490 nm) from computer
screens, televisions, and cell phones is 99 to 1000 times
less than that of sunlight and has not shown worsening
in patients with melasma. In a controlled study, Duteil
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et al9 showed that at a 20-cm distance from melasma
lesions, the maximized use of a high-intensity computer screen for 8 hours per day during a 5-day period
did not worsen melasma lesions.

2 forms, eumelanin and the sulfur-containing pheomelanin (found mostly in fair-skinned individuals with
red hair).6,10,27-29 Melanin’s absorption spectrum
ranges from 200 to 900 nm, with the peak absorption
varying based on melanin moiety.1,6,10,30,31 Keratins
are the filamentous proteins of the epidermis and the
IMPACT OF VL ON SKIN HEALTH:
major constituent of this layer; thus, the primary
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part explaining the difference
understand the impact of VL
in penetration depth for blue
on skin pathologies that
and red light into the epidermis and dermis.25,33,34
leads to the induction of oxidative stress, erythema,
Hemoglobin, consisting of 4 polypeptide chains, each
melanogenesis, and hyperpigmentation.1,4,6,10-15
bound to a molecule of heme, is the dominant
VL’s effects on skin are associated with a greater
absorber of light in the dermis.25,35 Hemoglobin has
penetration depth of this waveband into the layers of
a peak absorption of VL in the blue (418 nm) and
the skin relative to UV radiation. Red light has been
yellow/orange (542/577 nm) waveband, with the
shown to penetrate the full thickness of the
maximum absorption directly related to the erythroepidermis and dermis, reaching the subcutaneous
cyte concentration.1,6,25 Opsins (OPNs) are a large
adipose layer,16-21 demonstrating the proportionality
group of light-sensitive, G proteinecoupled receptors
of the wavelength to the depth of penetration and its
responsible for triggering signaling cascades when
inverse relationship with energy,6,22,23 while blue
activated by various wavelengths of light, including VL,
light, with its higher energy, has less penetration. The
resulting in VL phototransduction.6,36-38 Identified skin
penetration depth for a 63% reduction in incident
OPN’s activation wavelengths range from 380 to
intensity ranges from 90 to 230 microns for 400 to
400 nm (OPN4, OPN5) to as high as 557 to 560 nm
500 nm and from approximately 0.5 to 1 mm for the
(OPN-1-LW). Various cell types in the epidermis and
longer VL wavelengths in Caucasian skin (Fig 2). Of
dermis, including melanocytes, keratinocytes, fibronote, the penetration depth decreases with an
blasts, and hair follicle stem cells, have been shown to
increase in pigmentation.6,16,24
have opsin receptors.6,36,38-43 The group of carotenoids
in human skin includes a-carotene, g-carotene,
VL molecules in skin
ß-carotene, lycopene, lutein, and zeaxanthin and their
The depth of VL penetration is influenced by the
isomers.44,45 The distribution of carotenoids in human
reflection, scattering, and absorption mediated not
skin depends on the areas of skin examined and
only by the skin’s physical barrier but also by the VL
significantly varies from individual to individual.44,46
chromophores in the skin and the Fitzpatrick skin type
6,16-18,25
The protective role of carotenoids in the skin centers
(FST).
The primary VL-scatter and absorption
on the powerful antioxidant capacity of the molecules,
molecules in the skin include hemoglobin, melanin,
especially as quenchers of reactive oxygen species
keratin, bilirubin, carotene, lipids, and other structures,
(ROS).44,47,48
including cell nuclei and filamentous proteins. The
individual contributions from secondary chromophores may be considered separately.7,16-18,25
VL-mediated pathologies/reactions
VL-induced/exacerbated pathologies and reacMelanin and keratins are the primary VL absorbers
tions include erythema, post-inflammatory hyperand scatterers in the epidermis, and while hemoglobin
pigmentation, melasma, and photodermatoses.6 In
is the dominant absorber, collagen is the major VL
26
scatter in the dermis. Melanin in human skin exists in
FSTs I to III, VL has been shown to induce immediate
d
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Abbreviations used:
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RNS:
ROS:
VL:

Fitzpatrick skin type
opsin
reactive nitrogen species
reactive oxygen species
visible light

erythema.49 In FSTs IV to VI, erythema may not be
readily apparent clinically; however, recent spectroscopic studies using diffuse reflectance spectroscopy
demonstrate immediate and prolonged VL-induced
erythema in dark-skinned individuals.12,14,50 While
UV-induced erythema is the result of capillary
dilatation in the papillary dermis, VL-induced erythema appears to be the result of the dilatation of
vessels of the subpapillary plexus.50 VL-induced
pigmentation, including post-inflammatory hyperpigmentation, is exacerbated and prolonged in
patients with FSTs IV to VI as compared to UVA1einduced pigmentation.6,50,51 Exposure to VL can
induce inflammatory responses, leading to the stimulation of melanocytes, via ROS, resulting in the
exacerbation of preexisting hyperpigmentation.52-54
Melasma, the acquired facial pigmentary disorder
observed more frequently in FSTs IV to VI, can be
further exacerbated with VL exposure.55,56 Lastly, VL
is the action spectrum of some patients with photodermatoses, including solar urticaria, chronic actinic
dermatitis, polymorphous light eruption, and cutaneous porphyrias.13,50,57
Free radicals and ROS generated by VL and
impact on skin health
Efforts are underway to better understand the
underlying mechanisms through which VL impacts
skin health, including melanogenesis, inflammation,
and DNA damage.4-6,8,11,12,14,15,49,50,58-60 One important contributing factor is the VL induction of free
radicals and ROS, leading to a cascade of events
altering skin health, including the induction of

proinflammatory cytokines, matrix metalloproteinases, and melanogenesis.4-6,8,11,12,14,15,49,50,58-60
Until recently, the generation of reactive species,
including ROS and reactive nitrogen species (RNS),
was attributed exclusively to UV radiation; however,
recent studies have demonstrated the significant
impact of VL induction of these damaging species
and the subsequent activation of inflammatory cytokines and matrix metalloproteinases.50,61 In ex vivo
skin explant studies, results demonstrate an estimated
50% generation of ROS attributed to VL exposure,
compared to 4% attributed to UV-B and 46% to UV-A
exposure.62 Studies indicate that VL-mediated ROS
and RNS generation can damage the skin barrier,
leading to photoaging, hyperpigmentation, and melasma, especially in FSTs IV to VI.11,63-67 ROS generation leads to bystander damage to healthy skin cells
and the alteration of endogenous antioxidant levels
important for preventing additional skin damage.68,69
Further, in melanin-containing cells, VL-induced ROS
and RNS can cause radiation-independent pyrimidine
dimer formation.6,31,51,70,71
Though a high amount of free radical formation is
mediated by UV radiation, studies have revealed that
approximately 50% of free radicals are induced by VL
and infrared radiation (IR), findings that were
confirmed by in vivo studies showing the VL- and
IR-induced degradation of cutaneous carotenoid
antioxidants.62,69,72,73 The excess generation of
free-radical formation exceeding the free radical
threshold value is detrimental to overall skin health,
leading to DNA damage and melanogenesis.62
The cascade of events initiated by the induction of
free radicals and reactive species results in the
elevation of proinflammatory mediators and tissue
destructive enzymes, including the matrix metalloproteinases, resulting in DNA and tissue damage
associated with photoaging and melanogenesis.61,74,75 More recently, the induction of free
radicals has been identified to originate via activation
of the Opsin-3 receptor.39

Fig 1. Electromagnetic spectrum.
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Fig 2. Visible light: depth of penetration.16 A, Red light penetrates the full thickness of the
epidermis and dermis, reaching the subcutaneous adipose layer, while blue light has less
penetration, demonstrating the proportionality of the wavelength to the depth of penetration and
inverse relationship to energy. B, Schematic of depth of penetration, all sunlight. IR, Infrared.

VL-induced melanogenesis is most pronounced
in FSTs IV to VI,12,14,52 with reports of both transient
and long-lasting (up to 8 weeks) pigmentation in
human skin, dependent upon the total dose.59,76,77

It has been proposed that the production of immediate pigmentation after VL exposure is photochemical in nature, while delayed pigmentation
results from neo-melanogenesis.14 VL exposure in
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Fig 3. Role of radical quenchers and antioxidants in limiting UV/visible light-induced skin
damage. Radical quenchers function by limiting the generation of reactive species, while
antioxidants neutralize ROS and RNS. Antioxidant molecules, such as licochalcone A, function
by enhancing cellular tolerance to free radicals via the Nrf2 pathway. RNS, Reactive nitrogen
species; ROS, reactive oxygen species; VIS, visible light.

FSTs IV to VI leads to the activation of the OPN3
melanocyte sensor, initiating a cascade of reactions
culminating in the increase of the melanogenesis
enzymes tyrosinase and dopachrome tautomerase.
Additionally, VL induces the formation of a protein
complex between tyrosinase and dopachrome
tautomerase instrumental for maintaining tyrosinase activity in FST III and higher, leading to
hyperpigmentation.14 The overall impact of VL on
the induction of reactive species results in the
activation of multiple pathways, culminating in
DNA damage via ROS and RNS, hyperpigmentation,
and melanogenesis induced by tyrosinase activity
and photoaging, with the result of the stimulation of
inflammatory mediators and destructive matrix
metalloproteinases affecting both the appearance
and the architecture of the skin barrier.

ROLE OF ANTIOXIDANTS IN PREVENTING
SKIN DAMAGE
Oxidative stress mediated by both UV and VL
initiates multiple pathways affecting skin health, as
previously described. Natural endogenous antioxidants have evolved to protect the skin from environmental stimuli and ensure skin rejuvenation and
protection. These endogenous antioxidants and free
radical scavengers include glutathione, uric acid,
a-tocopherol, squalene, coenzyme Q10, and
others.78 Unfortunately, this natural protective system is not unlimited when the skin is exposed to

Fig 4. The effects of antioxidant licochalcone A on the
reduction of ROS79 are significant increase in reduction in
percent ROS with the addition of licochalcone A to
sunscreen. LicA, Licochalcone A; PF, protection factor;
ROS, reactive oxygen species; SPF, sun protection factor.

excessive UV and VL, and the breakdown of this
system can occur, leading to a disruption of skin
health, including DNA damage, hyperpigmentation,
and
melanogenesis.4-7,11,12,14,15,49,50,58-60
One
approach to providing additional photoprotection
is via the use of supplemental antioxidants and
radical quenchers to support or enhance the skin’s
endogenous system (Fig 3).
Several exogenous antioxidants and free radical
scavengers have been identified, including vitamin E
(a-tocopherol), vitamin C, licochalcone A, and
diethylhexyl syringylidene malonate.79,80 Vitamin E
is a potent antioxidant that inhibits the production of
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ROS molecules when lipids undergo oxidation and
during the propagation of free radical reaction.81,82
Due to vitamin E’s peroxyl radical-scavenging activity, it can aid in the protection of phospholipids and
fatty acids in the skin’s membrane phospholipids,83
and recent studies demonstrated vitamin E inhibition
of UV-Aeinduced cyclobutene pyrimidine dimers
and oxidatively generated DNA damage in keratinocytes.84 Vitamin C (ascorbic acid) is usually present
in high concentrations in the skin; however, several
reports have demonstrated low levels of vitamin C in
aged or photodamaged skin due to excessive exposure to oxidative stress stimulants, including pollutants and UV radiation.85-88 Vitamin C’s antioxidant
activity is maximized when present in conjunction
with vitamin E; when combined, they act to limit
oxidative damage to cell membrane structures.89-94
Licochalcone A is a root extract of Glycyrrhiza
inflata and has been identified as a potent antioxidant, inhibiting UV-induced ROS generation, and an
activator of the Nrf transcription factor, a key player
in the cellular stress response due to its regulation of
cytoprotective genes.79,95,96 Mann et al79 recently
demonstrated a decrease in VL- and UV-induced ROS
formation to a level equivalent to unirradiated
fibroblast cells, or even below, when irradiated
with UV and VL. Licochalcone A also showed protective effects on cutaneous carotenoids in vivo
(Fig 4). Taken together, the use of exogenous
antioxidants and radical scavengers can supplement
the endogenous antioxidant system of the skin,
aiding in overall photoprotection.

INTELLIGENT DESIGN OF
NEXT-GENERATION PHOTOPROTECTION
AGAINST UV- AND VL-INDUCED SKIN
DAMAGE
Given the increased awareness of the need for
photoprotection, not only from UV-A and UV-B
radiation but also from VL, it is imperative to work
toward establishing novel approaches to the development of photoprotection options for patients with
all FSTs. Currently, UV filters utilized in sunscreens
are either organic (ie, chemical), or inorganic (ie,
mineral) (Table I), with the primary focus on absorption in the UV-A/UV-B range.
Increases in the availability of photoprotection
products that include VL protection are emerging
and advancing, focused on either VL blocking (ie,
tinted sunscreens) or the generation of reactive
species and radical quenching (ie, antioxidant sunscreens). The inorganic or physical filters currently
available center on the ability of naturally occurring
minerals (ie, titanium dioxide, zinc oxide, and iron
oxide) to reflect and scatter VL when the particle

MARCH 2022

Table I. Approved UV filters in the 1999 US Food
and Drug Administration Sunscreen Monograph58
Active ingredient

Avobenzone
Cinoxate
Dioxybenzone
Ensulizole
Homosalate
Meradimate
Octinoxate
Octisalate
Octocrylene
Oxybenzone
Padimate O
Sulisobenzone
Titanium Dioxide
Zinc Oxide

Absorption

Maximum
concentration (%)

UV-A
UV-B
UV-B, UV-A2
UV-B
UV-B
UV-A2
UV-B
UV-B
UV-B, UV-A2
UV-B, UV-A2
UV-B
UV-B, UV-A2
UV-B, UV-A2, UV-A1
UV-B, UV-A2, UV-A1

3
3
3
4
15
5
7.5
5
10
6
8
10
25
25

Adapted from Geisler et al58 with permission from the Journal
American Academy of Dermatology, Elsevier.

sizes are [200 nm15,97,98; however, the large-sized
particles create a residual whitish appearance on the
skin, making them noncosmetically attractive, especially in FSTs IV to VI.97,98 Attempts to utilize
micronized zinc and titanium particles have resulted
in improved skin appearance but decreased VLblocking capacity.15,99,100 Early attempts to develop
antioxidant-based VL sunscreens (ie, vitamin E
cream) demonstrated no effects on VL-induced
pigmentation,101 while efforts of the use of antioxidant complexes showed less pigmentation immediately after VL irradiation compared to untreated sites
but no statistically significant differences in pigmentation after 7 days.13,60 More recently, Ezekwe et al102
presented preliminary results demonstrating a significant decrease in clinical scores for hyperpigmentation at day 7 post-VL 1 UV-A1 irradiation using
tinted organic sunscreen compared to an irradiated
untreated control. Recent advances in the incorporation of antioxidants and radical scavengers using
simple antioxidants blended into sunscreen formulations, thereby addressing the VL induction of ROS/
RNS, have looked promising.
Lyons et al103 showed that an antioxidant blend
topically applied to the skin containing a variable
concentration of a singlet oxygen quencher (diethylhexyl syringylidene malonate at 1% and 2%) and
fixed concentrations of vitamin E (0.25%) and vitamin
C (0.01%) can inhibit erythema in FST I to III and
reduce pigmentation in FST IV to VI caused by VL 1
UV-A1. Ruvolo et al (unpublished data) demonstrated
a significant reduction in VL-induced hyperpigmentation with sunscreen containing a vitamin E, vitamin C,
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Fig 5. Effects of antioxidant-enriched sunscreen formulations. Cross-polarized images from
sites exposed to 380 J/cm2. U: Untreated control: U1, immediate; U2, 24 hours; and U3, 7 days
after exposure. A: Sunscreen SPF 50, no antioxidants: A1, immediate; A2, 24 hours; and A3,
7 days after exposure. B: Tinted sunscreen, SPF 20 (10.66% titanium dioxide): B1, immediate;
B2, 24 hours; and B3, 7 days after exposure. C: Sunscreen SPF 50 with 5 antioxidants (0.5%
diethylhexyl syringylidene malonate, 0.25% vitamin E, 0.025% vitamin C, 0.025% licochalcone
A, 0.01% glycyrrhetinic acid): C1, immediate; C2, 24 hours; and C3, 7 days after exposure. SPF,
Sun protection factor.

diethylhexyl syringylidene malonate, licochalcone A,
and glycyrrhetinic acid antioxidant mixture compared
to that treated with sunscreen without antioxidants.
The protection was equivalent to that offered by tinted
sunscreen (Figs 5 and 6).
This nontinted formulation may aid in the overall
compliance and adherence to use of photoprotective
sunscreens, especially in patients most vulnerable to
VL-induced pigmentation disorders, including those
with FSTs IV to VI.

promise as novel alternatives for photoprotection for
all skin types.
The authors thank Rene Alvarez, PhD, and Valerie
Sanders from Evince Communications for providing editorial support, including development of the rough draft of
the manuscript, based exclusively on the outline and input
from the corresponding authors. This assistance was
funded via unrestricted educational funding from
Beiersdorf, Inc, which supported this work. The final
version solely represents the views of the authors and
was approved by each author prior to submission.

SUMMARY AND CONCLUSION
There is an increasing knowledge base on the
impact of VL on skin health, including erythema,
some photodermatoses, hyperpigmentation, and
melasma, especially in individuals with FST IV-VI.
Current photoprotection options for both UV and VL
are limited to tinted sunscreens, which are often not
cosmetically appealing and are, therefore, often
not utilized. The development of new filters that
cover the UV and VL ranges may help to fill this
gap in protection. In addition, recent advances in
understanding the role of VL’s induction of reactive
species has opened doors to the generation of
antioxidant-based formulations, which have shown
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E, 0.025% vitamin C, 0.025% licochalcone A, 0.01% glycyrrhetinic acid). SPF, Sun protection
factor.
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